521 related articles for article (PubMed ID: 11857318)
21. Modified classification for adenocarcinoma of the gastro-oesophageal junction.
Shearer CJ; Going JJ; Neilson LJ; Stuart RC
ANZ J Surg; 2007 Jul; 77(7):544-9. PubMed ID: 17610690
[TBL] [Abstract][Full Text] [Related]
22. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
[TBL] [Abstract][Full Text] [Related]
23. Identical cytokeratin expression pattern CK7+/CK20- in esophageal and cardiac cancer: etiopathological and clinical implications.
Driessen A; Nafteux P; Lerut T; Van Raemdonck D; De Leyn P; Filez L; Penninckx F; Geboes K; Ectors N
Mod Pathol; 2004 Jan; 17(1):49-55. PubMed ID: 14631371
[TBL] [Abstract][Full Text] [Related]
24. [Cytokeratin immunoreactivity patterns in the diagnosis of Barrett's esophagus].
Wang R; Xie J; Shen Y; Ren T
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1820-3. PubMed ID: 23268419
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of cytokeratin immunoreactivity pattern for distinction of Barrett's esophagus from intestinal metaplasia of the stomach.
Iwata T; Kurita N; Nishioka M; Hidenori M; Wakatsuki S; Sano T; Shimada M
Hepatogastroenterology; 2007 Sep; 54(78):1710-2. PubMed ID: 18019700
[TBL] [Abstract][Full Text] [Related]
26. Intestinal metaplasia of the gastric cardia.
Morales TG; Sampliner RE; Bhattacharyya A
Am J Gastroenterol; 1997 Mar; 92(3):414-8. PubMed ID: 9068460
[TBL] [Abstract][Full Text] [Related]
27. Adenocarcinoma of the esophagogastric junction: could the characteristics of adjacent intestinal metaplasia help in the understanding of biopathogenesis?
Cabrera RA; Chaves P; Crespo M; Pereira AD; Mendes de Almeida JC; Nobre Leitão C; Soares J
Dis Esophagus; 2002; 15(4):287-9. PubMed ID: 12472473
[TBL] [Abstract][Full Text] [Related]
28. Cytokeratin immunoreactivity patterns in short-segment Barrett's esophagus in Japanese patients.
Yagi K; Nakamura A; Sekine A
J Gastroenterol Hepatol; 2005 Jun; 20(6):929-34. PubMed ID: 15946143
[TBL] [Abstract][Full Text] [Related]
29. Cytokeratin expression in adenocarcinomas of the esophagogastric junction: a comparative study of adenocarcinomas of the distal esophagus and of the proximal stomach.
Taniere P; Borghi-Scoazec G; Saurin JC; Lombard-Bohas C; Boulez J; Berger F; Hainaut P; Scoazec JY
Am J Surg Pathol; 2002 Sep; 26(9):1213-21. PubMed ID: 12218578
[TBL] [Abstract][Full Text] [Related]
30. Intestinal metaplasia is the probable common precursor of adenocarcinoma in barrett esophagus and adenocarcinoma of the gastric cardia.
Ruol A; Parenti A; Zaninotto G; Merigliano S; Costantini M; Cagol M; Alfieri R; Bonavina L; Peracchia A; Ancona E
Cancer; 2000 Jun; 88(11):2520-8. PubMed ID: 10861428
[TBL] [Abstract][Full Text] [Related]
31. Intestinal and pancreatic metaplasia at the esophagogastric junction in patients without Barrett's esophagus.
Polkowski W; van Lanschot JJ; ten Kate FJ; Rolf TM; Polak M; Tytgat GN; Obertop H; Offerhaus GJ
Am J Gastroenterol; 2000 Mar; 95(3):617-25. PubMed ID: 10710048
[TBL] [Abstract][Full Text] [Related]
32. The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody.
Bayrak R; Haltas H; Yenidunya S
Diagn Pathol; 2012 Jan; 7():9. PubMed ID: 22268990
[TBL] [Abstract][Full Text] [Related]
33. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
McCluggage WG; Shah R; Connolly LE; McBride HA
Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
[TBL] [Abstract][Full Text] [Related]
34. Adenocarcinoma of the upper esophagus arising in heterotopic gastric mucosa: common pathogenesis with Barrett's adenocarcinoma?
Chatelain D; de Lajarte-Thirouard AS; Tiret E; Flejou JF
Virchows Arch; 2002 Oct; 441(4):406-11. PubMed ID: 12516606
[TBL] [Abstract][Full Text] [Related]
35. Does Cytokeratin7/20 immunoreactivity help to distinguish Barrett's esophagus from gastric intestinal metaplasia? Results of a prospective study of 75 patients.
Schilling D; Spiethoff A; Rosenbaum A; Hartmann D; Eickhoff A; Jakobs R; Weickert U; Rebe M; Bohrer MH; Riemann JF
Pathol Res Pract; 2005; 200(11-12):801-5. PubMed ID: 15792123
[TBL] [Abstract][Full Text] [Related]
36. Alteration of cytokeratin 7 and cytokeratin 20 expression profile is uniquely associated with tumorigenesis of primary adenocarcinoma of the small intestine.
Chen ZM; Wang HL
Am J Surg Pathol; 2004 Oct; 28(10):1352-9. PubMed ID: 15371952
[TBL] [Abstract][Full Text] [Related]
37. Intestinal metaplasia of the esophagus or esophagogastric junction: evidence of distinct clinical, pathologic, and histochemical staining features.
van Sandick JW; van Lanschot JB; van Felius L; Haringsma J; Tytgat GN; Dekker W; Drillenburg P; Offerhaus GJ; ten Kate FJ
Am J Clin Pathol; 2002 Jan; 117(1):117-25. PubMed ID: 11791590
[TBL] [Abstract][Full Text] [Related]
38. Sinonasal adenocarcinoma: evidence for histogenetic divergence of the enteric and nonenteric phenotypes.
Choi HR; Sturgis EM; Rashid A; DeMonte F; Luna MA; Batsakis JG; El-Naggar AK
Hum Pathol; 2003 Nov; 34(11):1101-7. PubMed ID: 14652810
[TBL] [Abstract][Full Text] [Related]
39. Small adenocarcinomas of the esophagogastric junction: association with intestinal metaplasia and dysplasia.
Cameron AJ; Souto EO; Smyrk TC
Am J Gastroenterol; 2002 Jun; 97(6):1375-80. PubMed ID: 12094853
[TBL] [Abstract][Full Text] [Related]
40. The significance and etiology of intestinal metaplasia of the esophagogastric junction.
Goldblum JR
Ann Diagn Pathol; 2002 Feb; 6(1):67-73. PubMed ID: 11842382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
